Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-24T11:18:55.539Z Has data issue: false hasContentIssue false
  • English
  • Français

Successful everolimus-eluting stent implantation into the left main trunk stenosis in the anomalous coronary artery after neo-aortic valve replacement in a 6-year-old boy

Part of: Interventional Cardiology

Published online by Cambridge University Press:  04 February 2019

Dai Asada ,
Hideshi Tomita  and
Takanari Fujii
Dai Asada*
Affiliation:
Department of Pediatric Cardiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
Hideshi Tomita
Affiliation:
Pediatric Heart Disease & Adult Congenital Heart Disease Center, Showa University Hospital, Shinagawa-ku, Tokyo, Japan
Takanari Fujii
Affiliation:
Pediatric Heart Disease & Adult Congenital Heart Disease Center, Showa University Hospital, Shinagawa-ku, Tokyo, Japan
*
Author for correspondence: D. Asada, 465 Kajiicho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan. Tel: +81 75 251 5832, Fax: +81 75 251 5833, E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

CHDs occasionally have coronary complications; however, stent implantation is technically difficult in small children. We reported a successful drug-eluting stent implantation into the congenital anomalous coronary artery in a 6-year-old boy. This treatment is useful for rescuing coronary stenosis, and dual antiplatelet therapy is important to prevent stent restenosis.

Keywords

Drug-eluting stentNorwood operationneo-aortic valve replacementanomalous coronary artery
Type
Brief Report
Information
Cardiology in the Young , Volume 29 , Issue 3 , March 2019 , pp. 448 - 450
Copyright
© Cambridge University Press 2019 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Cite this article: Asada D, Tomita H, Fujii T. (2019) Successful everolimus-eluting stent implantation into the left main trunk stenosis in the anomalous coronary artery after neo-aortic valve replacement in a 6-year-old boy. Cardiology in the Young29: 448–450. doi: 10.1017/S1047951118002512

References

1. Kaichi, S, Doi, H, Tsurumi, F, Heike, T. Long-term outcome of sirolimus-eluting stent implantation for left main coronary artery stenosis in infancy. Pediatr Cardiol 2011; 1: 94–97.Google Scholar
2. Shaher, RM, Puddu, GC. Coronary arterial anatomy in complete transposition of the great vessels. Am J Cardiol 1966; 3: 355–361.Google Scholar
3. Shimada, M, Hoashi, T, Kagisaki, K, Shiraishi, I, Yagihara, T, Ichikawa, H. Clinical outcomes of prophylactic Damus-Kaye-Stansel anastomosis concomitant with bidirectional Glenn procedure. J Thorac Cardiovasc Surg 2012; 1: 137–143.e1.Google Scholar
4. Hamzeh, RK, El-Said, HG, Moore, JW. Left main coronary artery compression from right pulmonary artery stenting. Catheter Cardiovasc Interv 2009; 2: 197–202.10.1002/ccd.21769Google Scholar
5. Arnold, R, Ley-Zaporozhan, J, Ley, S, et al. Outcome after mechanical aortic valve replacement in children and young adults. Ann Thorac Surg 2008; 2: 604–610.Google Scholar
6. Powell, DE, Tunick, PA, Rosenzweig, BP, et al. Aortic valve replacement in patients with aortic stenosis and severe left ventricular dysfunction. Arch Intern Med 2000; 9: 1337–1341.Google Scholar
7. Palmerini, T, Biondi-Zoccai, G, Della Riva, D, et al. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet 2012; 9824: 1393–1402.Google Scholar
8. Müller, MJ, Krause, U, Paul, T, Schneider, HE. Serum levels after everolimus-stent implantation and paclitaxel-balloon angioplasty in an infant with recurrent pulmonary vein obstruction after repaired total anomalous pulmonary venous connection. Pediatr Cardiol 2011; 7: 1036–1039.Google Scholar
9. Ueda, H, Kido, A, Matsuhisa, S, et al. Addition of cilostazol to aspirin therapy for secondary prevention of cardiovascular and cerebrovascular disease in patients undergoing percutaneous coronary intervention: a randomized, open-label trial. Am Heart J 2016; 173: 134–142.Google Scholar
10. Bratincsák, A, Salkini, A, El-Said, HG, Moore, JW. Percutaneous stent implantation into coronary arteries in infants. Catheter Cardiovasc Interv 2012; 2: 303–311.Google Scholar